The Food and Drug Administration (FDA) has approved Uplizna ® (inebilizumab-cdon) for the treatment of immunoglobulin G4-related disease (IgG4-RD) in adult patients.

AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

Checkpoint Therapeutics, Inc. ("Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, ...

AstraZeneca's IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

Kezar Life Sciences (KZR) reported topline results from the PORTOLA Phase 2a clinical trial evaluating zetomipzomib, a selective ...

Learn about enteropathic arthritis, a common extra-intestinal symptom of Crohn’s disease that affects the joints.

Checkpoint Therapeutics, Inc. ("Checkpoint") (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced financial ...

It's possible that trying a different type of hair extension could help, especially for people who experience scalp discomfort due to an allergic reaction ... treatment consists of high-dose ...

Two Emerging Infectious Diseases studies link bites from black-legged (deer) and western black-legged ticks to potentially ...

or a systemic steroid medication like prednisone if your symptoms are more widespread. It may take up to 10 days for the rash to resolve. Several common ingredients used in shampoo are known to cause ...